Hisense Tops Global Rankings in Q1 2025 for MiniLED, 100-inch and over, and Laser TVs
QINGDAO, China, June 6, 2025 /PRNewswire/ -- Hisense, a leading brand in…
ERA Congress: Long-term data show sustained efficacy and safety of zigakibart in patients with IgA nephropathy
VIENNA, June 5, 2025 /PRNewswire/ -- New 100-week data from the ongoing…
CM Global Services (CMGS) Secures Exclusive Multi-Year Logistics & Procurement Partnerships with Compass Mining and NovoMod
DENVER, May 22, 2025 /PRNewswire/ -- CM Global Services LLC (CMGS) proudly announces…
Johnson & Johnsons TAR-200 monotherapy demonstrates highest complete response rate reported to date with sustained clinical benefits in patients with certain types of bladder cancer
Phase 2b SunRISe-1 study shows more than 82 percent of patients achieved…
Mineralys Therapeutics Announces Publication of Pivotal Phase 2 Advance-HTN Results in the New England Journal of Medicine (NEJM)
April 23, 2025 17:23 ET | Source: Mineralys Therapeutics, Inc. – Significant…
Press Release: ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohns disease
ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and…
Press Release: ASH: rilzabrutinib demonstrated significant patient benefit in the first positive phase 3 study of a BTK inhibitor in ITP
ASH: rilzabrutinib demonstrated significant patient benefit in the first positive phase 3…